A writer shares his growing awareness of corruption in Big Pharma. He explores how chlorine dioxide was suppressed before ivermectin became controversial, revealing profit-driven motives in medicine.
I always knew corruption existed in every field. When it came to Big Pharma, I saw it as something abstract. There might be inflated contracts, outrageously profitable deals, or abusive markups here and there.
I assumed some products could have low-quality batches on a profit-driven line. I understood that when discoveries happened, companies focused on what sold best rather than what helped most. The story of chlorine dioxide shows how certain treatments get buried early, much like ivermectin later on. This pattern suggests deeper issues in how health solutions reach the public.
Personal experiences and observations led to questions about why some options face silence while others gain favor. The focus remains on profit over pure health benefits in many cases.
Original Author: Filipe Rafaeli | Source: Brownstone Institute
Comments